Works matching IS 10196439 AND DT 2023 AND VI 62 AND IP 6
Results: 9
Mechanisms of N6-methyladenosine modification in tumor development and potential therapeutic strategies (Review).
- Published in:
- International Journal of Oncology, 2023, v. 62, n. 6, p. N.PAG, doi. 10.3892/ijo.2023.5523
- By:
- Publication type:
- Article
New insights into lipid metabolism and prostate cancer (Review).
- Published in:
- International Journal of Oncology, 2023, v. 62, n. 6, p. N.PAG, doi. 10.3892/ijo.2023.5522
- By:
- Publication type:
- Article
[Corrigendum] CXCR1 promotes malignant behavior of gastric cancer cells in vitro and in vivo in AKT and ERK1/2 phosphorylation.
- Published in:
- International Journal of Oncology, 2023, v. 62, n. 6, p. N.PAG, doi. 10.3892/ijo.2023.5520
- By:
- Publication type:
- Article
Cancer testis antigen subfamilies: Attractive targets for therapeutic vaccine (Review).
- Published in:
- International Journal of Oncology, 2023, v. 62, n. 6, p. N.PAG, doi. 10.3892/ijo.2023.5519
- By:
- Publication type:
- Article
Effects of glycolysis on the polarization and function of tumor-associated macrophages (Review).
- Published in:
- International Journal of Oncology, 2023, v. 62, n. 6, p. N.PAG, doi. 10.3892/ijo.2023.5518
- By:
- Publication type:
- Article
Long non-coding RNAs in multiple myeloma (Review).
- Published in:
- International Journal of Oncology, 2023, v. 62, n. 6, p. N.PAG, doi. 10.3892/ijo.2023.5517
- By:
- Publication type:
- Article
Human leukocyte antigen and tumor immunotherapy (Review).
- Published in:
- International Journal of Oncology, 2023, v. 62, n. 6, p. N.PAG, doi. 10.3892/ijo.2023.5516
- By:
- Publication type:
- Article
[Retracted] MicroRNA-24 upregulation inhibits proliferation, metastasis and induces apoptosis in bladder cancer cells by targeting CARMA3.
- Published in:
- International Journal of Oncology, 2023, v. 62, n. 6, p. N.PAG, doi. 10.3892/ijo.2023.5515
- By:
- Publication type:
- Article
P2Y<sub>2</sub>R‑mediated transactivation of VEGFR2 through Src phosphorylation is associated with ESM‑1 overexpression in radiotherapy‑resistant‑triple negative breast cancer cells.
- Published in:
- International Journal of Oncology, 2023, v. 62, n. 6, p. N.PAG, doi. 10.3892/ijo.2023.5521
- By:
- Publication type:
- Article